Moderna Reports Positive Phase 3 Data for Combo Flu-COVID Vaccine with Strong Immunization Response and Higher Effectiveness
6 posts•EconomicsBusiness
Moderna announces positive Phase 3 data for a combination vaccine against influenza and COVID-19. The vaccine generates a strong immune response and is reported to be more effective than existing shots in a late-stage trial.
